Stockreport

Here are the most and least likely M&A targets in biotech, according to Truist [Seeking Alpha]

Madrigal Pharmaceuticals, Inc.  (MDGL) 
Last madrigal pharmaceuticals, inc. earnings: 2/26 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: madrigalpharma.com
PDF developer Madrigal Pharmaceuticals ( MDGL ) has become the least likely candidate, according to a survey conducted by Truist Securities. The Newsletters for Every In [Read more]